Skip to content
Close
SEARCH
Let's Talk
Let's Talk

SOFTWARE
Discover Icon

Discover

Visualize rapid, validated insights through real-world data.
Activate Square

Activate

Streamline data preparation with guardrailed workflows.
Substantiate Square

Substantiate

Transform real-world data into decision-grade evidence.
Generate Square

Generate

Safeguard privacy and ensure utility with AI-driven technology.

SERVICES

PARTNERSHIPS

Aetion has entered into an agreement to be acquired by Datavant, a leading health data platform company.   Learn more → 

GettyImages-1286971235 (1)

Advancing regulatory science

Aetion is an industry-leading RWE standard setter with deep regulatory relationships.

A global partner in shaping decision-grade evidence

As a trusted partner to global regulatory agencies and health technology assessment (HTA) bodies, Aetion sets the standard in advancing the use of real-world evidence (RWE) through transparent, fit-for-purpose methodologies and best-in-class scientific approaches. Our experts collaborate with leading industry groups to shape RWE best practices, while our peer-reviewed research redefines what it means to generate regulatory-grade evidence.

Let's Talk
GettyImages-1372508777

Benefits

Aetion offers generous benefits to its full-time employees, which currently can include:

benefit-1
Array of options for Medical, Dental, and Vision Insurance
benefit-2
Free membership to OneMedical
benefit-3
Flexible Spending Accounts for Healthcare and Dependent Care
benefit-4
Commuter Benefits for Parking and Transit
benefit-5
4% 401(k) match on Retirement Savings Plan
benefit-7
Unlimited paid time off
benefit-8
16 weeks of paid parental leave
benefit-9
One month paid sabbatical after five years at Aetion
benefit-11
Stipend towards wellness related expenses like gym memberships, fitness classes, and more
benefit-12
Company activities including happy hours, annual rally, summer social, lunch ‘n learns, and more!

The benefits offering may differ based on geographies where employees are based, when outside of the United States.

Regulators and HTAs

Decision-makers require decision-grade evidence. Aetion partners with regulatory bodies and HTAs to advance the use of RWE globally. These partners include:

Advocacy groups, professional societies, and convenors

Aetion’s solutions and experts help drive RWE standard advancement through collaborations with key industry groups, including:

Setting the standard in RWE

SPACE

A structured framework for creating a fit-for-purpose study design that can generate valid and transparent RWE

Read the paper -> 

 

CPT-106-103

SPIFD

A structured framework for determining which datasets are fit-for-purpose to answer a given research question

Read the paper -> 

 

Clin Pharma and Therapeutics - 2021 - Gatto - The Structured Process to Identify Fit‐For‐Purpose Data A Data Feasibility

SPIFD2

SPIFD2 harmonizes SPACE and SPIFD templates, calls for articulation of the hypothetical target trial and sources of bias that may arise, and incorporates STaRT-RWE reference.

Read the paper -> 

 

Clin Pharma and Therapeutics - 2023 - Gatto - A Structured Process to Identify Fit‐for‐Purpose Study Design and Data to

RCT DUPLICATE

Aetion’s partnership with FDA began in 2018 with the launch of the RCT DUPLICATE project, led by Brigham and Women’s Hospital (BWH) and Harvard Medical School (HMS). This project aimed to replicate the results of 30 published RCTs to see whether the use of RWE would lead to the same regulatory decisions, the final results of which were published in JAMA.

Read the paper -> 

 

jama_wang_2023_oi_230035_1712598871.82677-1

Experts in providing real world evidence solutions

Connect with us to work with the team advancing critical decisions in healthcare.
Let's Talk